Selected research
Industry Research
Intranasal Vaccine Industry Research Report 2026
Market perspective
The global Intranasal Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Intranasal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Intranasal Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Intranasal Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Intranasal Vaccine include Abbott, Beijing Wantai Biopharmaceutical Co., Ltd., Sanofi, GlaxoSmithKline, Changchun Baike Company, AstraZeneca, Serum Institute of India, PharmaJet and Crossject and INJEX Pharma GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Intranasal Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intranasal Vaccine Market by Company
Abbott
Beijing Wantai Biopharmaceutical Co., Ltd.
Sanofi
GlaxoSmithKline
Changchun Baike Company
AstraZeneca
Serum Institute of India
PharmaJet and Crossject
INJEX Pharma GmbH
BioDiem
Bharat Biotech
Antares Pharma
Intranasal Vaccine Segment by Type
Flu Vaccine
COVID-19 Vaccines
Intranasal Vaccine Segment by Application
Hospital
Clinic
Intranasal Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intranasal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intranasal Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intranasal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flu Vaccine
- COVID-19 Vaccines
Applications
- Hospital
- Clinic
Companies covered
- Abbott
- Beijing Wantai Biopharmaceutical Co., Ltd.
- Sanofi
- GlaxoSmithKline
- Changchun Baike Company
- AstraZeneca
- Serum Institute of India
- PharmaJet and Crossject
- INJEX Pharma GmbH
- BioDiem
- Bharat Biotech
- Antares Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Intranasal Vaccine Market Size (2021-2032)
- 2.2.2 Global Intranasal Vaccine Sales (2021-2032)
- 2.2.3 Global Intranasal Vaccine Market Average Price (2021-2032)
- 2.3 Intranasal Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Flu Vaccine
- 2.3.3 COVID-19 Vaccines
- 2.4 Intranasal Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Intranasal Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Intranasal Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Intranasal Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Intranasal Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Intranasal Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Intranasal Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Intranasal Vaccine, Established Date
- 3.9 Global Intranasal Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Intranasal Vaccine Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Beijing Wantai Biopharmaceutical Co., Ltd.
- 4.2.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
- 4.2.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
- 4.2.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
- 4.2.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Intranasal Vaccine Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Changchun Baike Company
- 4.5.1 Changchun Baike Company Company Information
- 4.5.2 Changchun Baike Company Business Overview
- 4.5.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Changchun Baike Company Intranasal Vaccine Product Portfolio
- 4.5.5 Changchun Baike Company Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Intranasal Vaccine Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
- 4.7 Serum Institute of India
- 4.7.1 Serum Institute of India Company Information
- 4.7.2 Serum Institute of India Business Overview
- 4.7.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Serum Institute of India Intranasal Vaccine Product Portfolio
- 4.7.5 Serum Institute of India Recent Developments
- 4.8 PharmaJet and Crossject
- 4.8.1 PharmaJet and Crossject Company Information
- 4.8.2 PharmaJet and Crossject Business Overview
- 4.8.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
- 4.8.5 PharmaJet and Crossject Recent Developments
- 4.9 INJEX Pharma GmbH
- 4.9.1 INJEX Pharma GmbH Company Information
- 4.9.2 INJEX Pharma GmbH Business Overview
- 4.9.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
- 4.9.5 INJEX Pharma GmbH Recent Developments
- 4.10 BioDiem
- 4.10.1 BioDiem Company Information
- 4.10.2 BioDiem Business Overview
- 4.10.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BioDiem Intranasal Vaccine Product Portfolio
- 4.10.5 BioDiem Recent Developments
- 4.11 Bharat Biotech
- 4.11.1 Bharat Biotech Company Information
- 4.11.2 Bharat Biotech Business Overview
- 4.11.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bharat Biotech Intranasal Vaccine Product Portfolio
- 4.11.5 Bharat Biotech Recent Developments
- 4.12 Antares Pharma
- 4.12.1 Antares Pharma Company Information
- 4.12.2 Antares Pharma Business Overview
- 4.12.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Antares Pharma Intranasal Vaccine Product Portfolio
- 4.12.5 Antares Pharma Recent Developments
5 Global Intranasal Vaccine Market Scenario by Region
- 5.1 Global Intranasal Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Intranasal Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Intranasal Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Intranasal Vaccine Sales by Region: 2027-2032
- 5.3 Global Intranasal Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Intranasal Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Intranasal Vaccine Revenue by Region: 2027-2032
- 5.4 North America Intranasal Vaccine Market Facts & Figures by Country
- 5.4.1 North America Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Intranasal Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Intranasal Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Intranasal Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Intranasal Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Intranasal Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Intranasal Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Intranasal Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Intranasal Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Intranasal Vaccine Market Facts & Figures by Country
- 5.7.1 South America Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Intranasal Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Intranasal Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Intranasal Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Intranasal Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Intranasal Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Intranasal Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Intranasal Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Intranasal Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Intranasal Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Intranasal Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Intranasal Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Intranasal Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Intranasal Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Intranasal Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Intranasal Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Intranasal Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Intranasal Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Intranasal Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Intranasal Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Intranasal Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Intranasal Vaccine Value Chain Analysis
- 8.1.1 Intranasal Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Intranasal Vaccine Production Mode & Process
- 8.2 Intranasal Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Intranasal Vaccine Distributors
- 8.2.3 Intranasal Vaccine Customers
9 Global Intranasal Vaccine Analyzing Market Dynamics
- 9.1 Intranasal Vaccine Industry Trends
- 9.2 Intranasal Vaccine Industry Drivers
- 9.3 Intranasal Vaccine Industry Opportunities and Challenges
- 9.4 Intranasal Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst